Global Dexrazoxane for Injection Market Growth 2025-2031

Publication ID:

LPI04255162

Publication Date:

April 23, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Dexrazoxane for Injection market size is predicted to grow from US$ 1960 million in 2025 to US$ 2751 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
An anti-tumor adjuvant drug that can be used to alleviate or reduce the myocardial toxicity caused by anthracycline antibiotics (such as doxorubicin) chemotherapy
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒exrazoxane for Injection Industry Forecast鈥� looks at past sales and reviews total world Dexrazoxane for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Dexrazoxane for Injection sales for 2025 through 2031. With Dexrazoxane for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dexrazoxane for Injection industry.
This Insight Report provides a comprehensive analysis of the global Dexrazoxane for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dexrazoxane for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Dexrazoxane for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dexrazoxane for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dexrazoxane for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Dexrazoxane for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
250mg
500mg
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Jiangsu Aosaikang Pharma
Chaiatai Tianqing
Hairun Pharma
Kissei Pharma
Gland Pharma
Eugia Pharma
Hikma Pharma
Clinigen Group
Pfizer
Aurobindo Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dexrazoxane for Injection market?
What factors are driving Dexrazoxane for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dexrazoxane for Injection market opportunities vary by end market size?
How does Dexrazoxane for Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dexrazoxane for Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Dexrazoxane for Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Dexrazoxane for Injection by Country/Region, 2020, 2024 & 2031
2.2 Dexrazoxane for Injection Segment by Type
2.2.1 250mg
2.2.2 500mg
2.2.3 Other
2.3 Dexrazoxane for Injection Sales by Type
2.3.1 Global Dexrazoxane for Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Dexrazoxane for Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Dexrazoxane for Injection Sale Price by Type (2020-2025)
2.4 Dexrazoxane for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Dexrazoxane for Injection Sales by Application
2.5.1 Global Dexrazoxane for Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Dexrazoxane for Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Dexrazoxane for Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Dexrazoxane for Injection Breakdown Data by Company
3.1.1 Global Dexrazoxane for Injection Annual Sales by Company (2020-2025)
3.1.2 Global Dexrazoxane for Injection Sales Market Share by Company (2020-2025)
3.2 Global Dexrazoxane for Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Dexrazoxane for Injection Revenue by Company (2020-2025)
3.2.2 Global Dexrazoxane for Injection Revenue Market Share by Company (2020-2025)
3.3 Global Dexrazoxane for Injection Sale Price by Company
3.4 Key Manufacturers Dexrazoxane for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dexrazoxane for Injection Product Location Distribution
3.4.2 Players Dexrazoxane for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Dexrazoxane for Injection by Geographic Region
4.1 World Historic Dexrazoxane for Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Dexrazoxane for Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Dexrazoxane for Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dexrazoxane for Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Dexrazoxane for Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Dexrazoxane for Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dexrazoxane for Injection Sales Growth
4.4 APAC Dexrazoxane for Injection Sales Growth
4.5 Europe Dexrazoxane for Injection Sales Growth
4.6 Middle East & Africa Dexrazoxane for Injection Sales Growth
5 Americas
5.1 Americas Dexrazoxane for Injection Sales by Country
5.1.1 Americas Dexrazoxane for Injection Sales by Country (2020-2025)
5.1.2 Americas Dexrazoxane for Injection Revenue by Country (2020-2025)
5.2 Americas Dexrazoxane for Injection Sales by Type (2020-2025)
5.3 Americas Dexrazoxane for Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dexrazoxane for Injection Sales by Region
6.1.1 APAC Dexrazoxane for Injection Sales by Region (2020-2025)
6.1.2 APAC Dexrazoxane for Injection Revenue by Region (2020-2025)
6.2 APAC Dexrazoxane for Injection Sales by Type (2020-2025)
6.3 APAC Dexrazoxane for Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dexrazoxane for Injection by Country
7.1.1 Europe Dexrazoxane for Injection Sales by Country (2020-2025)
7.1.2 Europe Dexrazoxane for Injection Revenue by Country (2020-2025)
7.2 Europe Dexrazoxane for Injection Sales by Type (2020-2025)
7.3 Europe Dexrazoxane for Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dexrazoxane for Injection by Country
8.1.1 Middle East & Africa Dexrazoxane for Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Dexrazoxane for Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Dexrazoxane for Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Dexrazoxane for Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dexrazoxane for Injection
10.3 Manufacturing Process Analysis of Dexrazoxane for Injection
10.4 Industry Chain Structure of Dexrazoxane for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dexrazoxane for Injection Distributors
11.3 Dexrazoxane for Injection Customer
12 World Forecast Review for Dexrazoxane for Injection by Geographic Region
12.1 Global Dexrazoxane for Injection Market Size Forecast by Region
12.1.1 Global Dexrazoxane for Injection Forecast by Region (2026-2031)
12.1.2 Global Dexrazoxane for Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dexrazoxane for Injection Forecast by Type (2026-2031)
12.7 Global Dexrazoxane for Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Jiangsu Aosaikang Pharma
13.1.1 Jiangsu Aosaikang Pharma Company Information
13.1.2 Jiangsu Aosaikang Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.1.3 Jiangsu Aosaikang Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jiangsu Aosaikang Pharma Main Business Overview
13.1.5 Jiangsu Aosaikang Pharma Latest Developments
13.2 Chaiatai Tianqing
13.2.1 Chaiatai Tianqing Company Information
13.2.2 Chaiatai Tianqing Dexrazoxane for Injection Product Portfolios and Specifications
13.2.3 Chaiatai Tianqing Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Chaiatai Tianqing Main Business Overview
13.2.5 Chaiatai Tianqing Latest Developments
13.3 Hairun Pharma
13.3.1 Hairun Pharma Company Information
13.3.2 Hairun Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.3.3 Hairun Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hairun Pharma Main Business Overview
13.3.5 Hairun Pharma Latest Developments
13.4 Kissei Pharma
13.4.1 Kissei Pharma Company Information
13.4.2 Kissei Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.4.3 Kissei Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kissei Pharma Main Business Overview
13.4.5 Kissei Pharma Latest Developments
13.5 Gland Pharma
13.5.1 Gland Pharma Company Information
13.5.2 Gland Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.5.3 Gland Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Gland Pharma Main Business Overview
13.5.5 Gland Pharma Latest Developments
13.6 Eugia Pharma
13.6.1 Eugia Pharma Company Information
13.6.2 Eugia Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.6.3 Eugia Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Eugia Pharma Main Business Overview
13.6.5 Eugia Pharma Latest Developments
13.7 Hikma Pharma
13.7.1 Hikma Pharma Company Information
13.7.2 Hikma Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.7.3 Hikma Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hikma Pharma Main Business Overview
13.7.5 Hikma Pharma Latest Developments
13.8 Clinigen Group
13.8.1 Clinigen Group Company Information
13.8.2 Clinigen Group Dexrazoxane for Injection Product Portfolios and Specifications
13.8.3 Clinigen Group Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Clinigen Group Main Business Overview
13.8.5 Clinigen Group Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Dexrazoxane for Injection Product Portfolios and Specifications
13.9.3 Pfizer Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Aurobindo Pharma
13.10.1 Aurobindo Pharma Company Information
13.10.2 Aurobindo Pharma Dexrazoxane for Injection Product Portfolios and Specifications
13.10.3 Aurobindo Pharma Dexrazoxane for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aurobindo Pharma Main Business Overview
13.10.5 Aurobindo Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂